Cogent Biosciences, Inc.

US$31.64As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:COGTHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR 18.77%
Div yield —
ROE (109.74%)
Biotechnology
Beta (5Y) 0.34
PE TTM —
TSR TTM 94.14%
Mkt cap US$5.507B
ROIC (46.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$36
14.92%
(29.47%)
Hold 6|5|12|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.48
0.49
0.51
0.56
3.49%
1.17%
7.20%
20.08%
Revenue$M
407.1
401.4
398.4
404.6
4.66%
6.27%
0.12%
3.02%
Peers (US$5.507B)
Cap (US$)
PE
5.487B
84.56x
Capital
TTM
5Y
10Y
Leveragex
11.23
0.187
0.186
EBIT/Intx
0.431
0.410
0.357
Own earn%
(21.18)
18.68
9.99
Sh yield%
50.88
9.22
11.75
Owners
Insiders/Inst%
4.72
58.72
Short interest%
0.78
SBC / revenue%
1.23
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
18–27
$1 testx
−0.1
Incr. ROIC%
15